Shanghai Allist Pharmaceuticals Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,347.8 million compared to CNY 517.72 million a year ago. Revenue was CNY 1,347.8 million compared to CNY 517.72 million a year ago.

Net income was CNY 410.43 million compared to CNY 53.93 million a year ago. Basic earnings per share from continuing operations was CNY 0.91 compared to CNY 0.12 a year ago. Diluted earnings per share from continuing operations was CNY 0.91 compared to CNY 0.12 a year ago.